The Influence of Overweight on the Structural and Geometric Parameters of the Left Ventricular Myocardium and the Daily Blood Pressure Profile in Middle-aged Military Personnel
DOI:
https://doi.org/10.61841/0a69a055Keywords:
Arterial Hypertension, Overweight, Echocardiography, Left Ventricular RemodelingAbstract
One of the leading risk factors for the development of arterial hypertension is undoubtedly overweight. The purpose of this study was to study the effect of excess body mass index on the structural and geometric parameters of the left ventricular myocardium and the daily blood pressure profile in middle-aged military personnel with arterial hypertension. The study included 73 patients suffering from arterial hypertension (AH) of 1-2 degrees, male, aged 20 to 45 years, with stage 1 hypertension. With an increase in the level of body weight in military personnel with hypertension, there is an increase in the incidence of remodeled left ventricular myocardium and an increase in the diagnosis of adverse daily blood pressure profiles. Based on the results of complex therapy (hypotensive therapy), it is also necessary to pay attention to actions that are aimed at normalizing body weight.
Downloads
References
[1] Arch. Intern. Med., (1997). Joint National Committee on Prevention, Detection, Evaluation and Treatment
of high blood pressure. The Sixth Report of the Joint National Committee on Prevention, Detection,
Evaluation and Treatment of High Blood Pressure. doi:157: 2413-2446.
[2] Avelar, E., Cloward, T. V., Walker, J. M., et al. (2007). Left ventricular hypertrophy in severe obesity:
interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension, 49, 34–39.
[3] Chazov E. I. (2014). Recommendations for the management of patients with hypertension with metabolic
disorders. In E. I. Chazov, Yu. a. Karpov, A. I. Martynov, I. E. Chazova, Cardiological Bulletin, Vol. 9(1),
1-15.
[4] Chumakova, G. A., Veselovskaya, N. G., Kozarenko, A. A., & Vorobyova, Yu. V. (2012). Features of
morphology, structure, and function of the heart in obesity. Russian Journal of Cardiology, 4 (96), 93-99.
[5] Devereux, R.B.(1977). Echocardiographic determination of left ventricular mass in man. Anatomic
validation of the method. In R.B. Devereux, N. Reichek, Circulation. Vol. 55(4), 613–618.
[6] EurJEchocardiography. (2006). Recommendations for Chamber Quantification: A Report from the
American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber
Quantification Writing Group, Developed in Conjunction with the European Association of
Echocardiography, a Branch of the European Society of Cardiology, 7(79), 108.
[7] Flegal, K.M., Kit, B.K., Orpana, H., & Graubard, B.I. (2013). Association of all-cause mortality with
overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.
JAMA, doi:309:71–82.
[8] Hall, J. E., DoCarmo, J.M., Da Silva, A.A., Wang, Z., & Hall, M.E. (2015). Obesity-induced hypertension:
interaction of neurohumoral and renal mechanisms. Circ Res, doi:116:991–1006.
[9] Hansen, T. W., Li, Y., Boggia, J., Thijs, L., Richart, T., & Staessen, J.A. (2011) Predictive role of the night—
Time blood pressure. Hypertension, doi: 57:3–10.
[10] Ignatova, G. L., L.,Belsner, M. S., & Blinova, E. V. (2015). Correction of metabolic syndrome in patients with severe obstructive pulmonary disease. Cardiology, 2, 57-59.
[11] Jolly, K. (2014). Improving outcomes for patients with obesity. In K. Jolly, R. Chambers Practitioner. JulAvg. 258 (1773), 29-31.
[12] Kalantari, S., Khalili, D., Asgari, S., Fahimfar, N., Hadaegh, F., Tohidi, M., & Azizi, F. (2017). Predictors
of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health, doi:28;17(1):915.
[13] Kobalava, Z. D. (2000). Arterial hypertension and obesity: random association or causal relationship.
KlinfarmakolTer, 9(3), 35-39.
[14] Konradi, A. O. (2003). Remodeling of the heart and large vessels in hypertension (Abstract of the
dissertation), SPb, 38.
[15] Kryukov, N. N., Kiseleva, E. V., Kiseleva, G. I., Baybursyan, E. D., & Underovich, Yu. V. (2014).
Inflammatory cytokines in patients with arterial hypertension (pp. 263-264). Kazan: Russian national
Congress of cardiologists "Innovations and progress in cardiology"
[16] Lang, R. M., Badano, L., & Afilalo, J. (2015). Chamber Quantification Writing Group, American Society of
Echocardiography’s Guidelines, Standards Committee, European Association of Echocardiography.
Recommendations for cardiac chamber quantification by echocardiography: an update from the American
Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc
Echocardiogr, doi:28: 1–39.
[17] Marwick, T.H., Gillebert, T.C., & G. Aurigemma [et al.]. (2015). Recommendations on the use of
echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging
(EACVI) and the American Society of Echocardiography (ASE). In Eur. HeartJ. Cardiovasc. Imaging. Jun.,
Vol. 16(6), 577–605.
[18] Navas-Nacher, E., Colangelo, L., & Beam, C. (2001). (Greenland Ph). Risk Factors for Coronary Heart
Disease in men 18 to 39 years of age. Ann Intern Med, doi: 134(6):433-439.
[19] Nishimura, R. (2005). The Study TO Prevent Non-Insulin Dependent Diabetes Mellitus trial (acarbose).
Nihon rinsho. Japanese Journal of Clinical Medicine. Vol. 63. P. 478–482.
[20] Ohkubo, T., Imai, Y., Tsuji, I., Nagai, K., Watanabe, N., Minami, N., Itoh, O., Bando, T., Sakuma, M.,
Fukao, A., Satoh, H., Hisamichi, S., & Abe, K. (2002). Prediction of mortality by ambulatory blood
Pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens.
DOI: 15: 357–364.
[21] Saint Petersburg. (2017). Diagnostics, treatment, prevention of obesity and associated diseases (national
clinical recommendations). C-57.
[22] Van Bortel, L.M., Laurent, S., & Boutouyrie, P., et al. (2012). Expert consensus document on the
measurement of aortic stiffness in daily practice. using carotid-femoral pulse wave velocity. J Hypertens,
doi: 30: 445-8.
[23] Whitlock, G., Lewington, S., Sherliker, P., Clarke, R., Emberson, J., Halsey, J., Qizilbash, N., Collins, R.,
& Peto, R. (2009). Prospective Studies Collaboration, Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet, doi: 373: 1083–1096.
[24] Zanchetti, A. Arterial hypertension and hypertrophy of the left ventricle of the heart. International trends in the study of arterial hypertension, 17, 3-5.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
